Achieve Life Sciences, Inc.

ACHV

Exchange: Nasdaq
Industry: In Vitro & In Vivo Diagnostic Substances
SEC CIK: 0000949858

SEC filings (opens in a new tab)

In the last 90 days, Achieve Life Sciences, Inc. insiders filed 0 open-market purchases and 1 sale; 111 institutions reported holding it in 13F filings for Q2 2026, worth $538.7M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Achieve Life Sciences, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021 All holders in Q1 2021

13F holders of ACHV: Q1 2021 compared with Q2 2021
Measure	Q1 2021	Q2 2021	Change
Holders	16	29	+13
Shares	1.01M	1.95M	+941.3K (+93.5%)
Value	$11.7M	$17.5M	+$5.84M (+50.1%)

New holders (17)

Institutions that held Achieve Life Sciences, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to ACHV in Q2 2021
Institution	Shares	Value	% of portfolio
683 Capital Management, LLC	125,000	$1.12M	0.06%
Altium Capital Management LP	122,000	$1.10M	0.25%
Clearline Capital LP	121,812	$1.09M	0.16%
Millennium Management LLC	101,986	$916.0K	0.00%
Two Sigma Investments, LP	44,419	$399.0K	0.00%
Two Sigma Advisers, LP	43,255	$388.0K	0.00%
QS Investors, LLC	34,050	$306.0K	0.00%
Royal Bank of Canada	30,700	$276.0K	0.00%
Dimensional Fund Advisors LP	27,493	$247.0K	0.00%
Walleye Capital LLC	27,307	$245.0K	0.01%
Oppenheimer & Co Inc	23,000	$207.0K	0.00%
Occudo Quantitative Strategies LP	19,082	$171.0K	0.03%
Northern Trust Corp	17,096	$153.0K	0.00%
Pura Vida Investments, LLC	17,000	$153.0K	0.01%
State Street Corp	14,761	$133.0K	0.00%
UBS Group AG	589	$6.00K	0.00%
FMR LLC	1	$0	0.00%

Sold out (4)

Institutions that held Achieve Life Sciences, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of ACHV in Q2 2021
Institution	Shares, Q1 2021	Value, Q1 2021
Ikarian Capital, LLC	284,151	$3.29M
Boothbay Fund Management, LLC	33,389	$387.0K
Citadel Advisors LLC	12,456	$144.0K
Gemmer Asset Management LLC	300	$3.00K